Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 12-Nov-19 4:41 PM View:  | Wysenski Nancy Director | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 6,274 | -- | -- | (100%) 6.27K to 0 | |
| 12-Nov-19 4:40 PM View: | Stalfort Sean Director | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition (change in control) | 635,665 | $27.50 | $17,480,800.00 | (100%) 635.66K to 0 | |
| 12-Nov-19 4:42 PM View: | Zaccardelli David President & CEO Director | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 76,647 | -- | -- | (100%) 76.65K to 0 | |
| 15-Nov-19 8:02 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition (other) | 3,125,850 | -- | -- | (100%) 3.13M to 0 | |
| 12-Nov-19 4:32 PM View: | Allen Lee F Md Phd Chief Medical Officer | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 9,635 | -- | -- | (100%) 9.63K to 0 | |
| 12-Nov-19 4:33 PM View: | Goldman Steven M. Director | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 5,000 | -- | -- | (100%) 5.0K to 0 | |
| 12-Nov-19 4:38 PM View: | Manning Paul B Director 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition (change in control) | 12,979,000 | $27.50 | $356,923,008.00 | (88%) 14.76M to 1.78M | |
| 12-Nov-19 4:39 PM View: | Novak Alfred J Director | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 6,901 | -- | -- | (100%) 6.9K to 0 | |
| 12-Nov-19 4:35 PM View: | Hoitt Jason Chief Commercial Officer | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 9,970 | -- | -- | (100%) 9.97K to 0 | |
| 12-Nov-19 4:36 PM View: | Jeffs Roger Director | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 66,993 | -- | -- | (100%) 66.99K to 0 | |
| 12-Nov-19 4:37 PM View: | Laliberte Kevin Sr. VP, Product Development | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 4,761 | -- | -- | (100%) 4.76K to 0 | |
| 12-Nov-19 4:38 PM View: | Manning Paul B Director 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition (change in control) | 1,783,230 | $27.50 | $49,038,700.00 | (100%) 1.78M to 0 | |
| 12-Nov-19 4:34 PM View: | Hahn Mark W Chief Financial Officer | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 9,024 | -- | -- | (100%) 9.02K to 0 | |
| 12-Nov-19 4:33 PM View: | Goldman Steven M. Director | Dova Pharmaceuticals Inc. (DOVA) | 12-Nov-19 | Disposition | 144,280 | -- | -- | (97%) 149.28K to 5.0K | |
| 02-Oct-19 4:21 PM View: | Zaccardelli David President & CEO Director | Dova Pharmaceuticals Inc. (DOVA) | 01-Oct-19 | Private Sale (Planned) | 5,275 | $27.90 | $147,172.00 | (6%) 81.92K to 76.65K | |
| 02-Oct-19 4:20 PM View: | Laliberte Kevin Sr. VP, Product Development | Dova Pharmaceuticals Inc. (DOVA) | 30-Sep-19 | Private Sale (Planned) | 3,696 | $28.00 | $103,488.00 | (44%) 8.46K to 4.76K | |
| 02-Oct-19 4:21 PM View: | Allen Lee F Md Phd Chief Medical Officer | Dova Pharmaceuticals Inc. (DOVA) | 30-Sep-19 | Private Sale (Planned) | 978 | $28.00 | $27,384.00 | (9%) 10.61K to 9.63K | |
| 02-Oct-19 4:20 PM View: | Hoitt Jason Chief Commercial Officer | Dova Pharmaceuticals Inc. (DOVA) | 30-Sep-19 | Private Sale (Planned) | 2,387 | $28.00 | $66,836.00 | (19%) 12.36K to 9.97K | |
| 02-Oct-19 4:20 PM View: | Hahn Mark W Chief Financial Officer | Dova Pharmaceuticals Inc. (DOVA) | 30-Sep-19 | Private Sale (Planned) | 775 | $28.00 | $21,700.00 | (8%) 9.8K to 9.02K | |
| 27-Sep-19 4:05 PM View: | Laliberte Kevin Sr. VP, Product Development | Dova Pharmaceuticals Inc. (DOVA) | 25-Sep-19 | Private Sale (Planned) | 3,100 | $20.00 | $62,000.00 | (27%) 11.56K to 8.46K | |
| 12-Aug-19 4:15 PM View: | Manning Paul B Director 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 09-Aug-19 | Purchase | 28,062 | $15.87 | $445,344.00 | < 1% 14.73M to 14.76M | |
| 01-Aug-19 4:31 PM View: | Laliberte Kevin Sr. VP, Product Development | Dova Pharmaceuticals Inc. (DOVA) | 31-Jul-19 | Private Sale (Planned) | 1,389 | $15.97 | $22,182.30 | (11%) 12.95K to 11.56K | |
| 16-Jul-19 4:29 PM View: | Hoitt Jason Chief Commercial Officer | Dova Pharmaceuticals Inc. (DOVA) | 15-Jul-19 | Private Sale (Planned) | 7,580 | $15.26 | $115,664.00 | (38%) 19.94K to 12.36K | |
| 11-Jul-19 8:31 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 11-Jul-19 | Purchase | 42,916 | $16.67 | $715,410.00 | 1% 3.67M to 3.71M | |
| 11-Jul-19 8:31 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 10-Jul-19 | Purchase | 12,354 | $16.89 | $208,659.00 | < 1% 3.65M to 3.67M | |
| 11-Jul-19 8:31 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 09-Jul-19 | Purchase | 29,834 | $16.61 | $495,543.00 | < 1% 3.62M to 3.65M | |
| 09-Jul-19 7:43 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 05-Jul-19 | Purchase | 50,000 | $16.46 | $823,000.00 | 1% 3.58M to 3.63M | |
| 03-Jul-19 8:28 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 03-Jul-19 | Purchase | 1,705 | $16.67 | $28,422.30 | < 1% 3.57M to 3.57M | |
| 03-Jul-19 4:24 PM View: | Zaccardelli David President & CEO Director | Dova Pharmaceuticals Inc. (DOVA) | 02-Jul-19 | Private Sale (Planned) | 10,450 | $15.94 | $166,608.00 | (11%) 92.37K to 81.92K | |
| 03-Jul-19 8:28 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 02-Jul-19 | Purchase | 715 | $16.14 | $11,540.10 | < 1% 3.57M to 3.57M | |
| 02-Jul-19 4:57 PM View: | Laliberte Kevin Sr. VP, Product Development | Dova Pharmaceuticals Inc. (DOVA) | 01-Jul-19 | Private Sale (Planned) | 1,191 | $14.17 | $16,876.50 | (8%) 14.14K to 12.95K | |
| 03-Jul-19 8:28 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 01-Jul-19 | Purchase | 18,121 | $14.24 | $258,043.00 | < 1% 3.55M to 3.57M | |
| 02-Jul-19 4:59 PM View: | Hahn Mark W Chief Financial Officer | Dova Pharmaceuticals Inc. (DOVA) | 01-Jul-19 | Private Sale (Planned) | 1,545 | $14.17 | $21,892.70 | (14%) 11.34K to 9.8K | |
| 02-Jul-19 4:58 PM View: | Jeffs Roger Director | Dova Pharmaceuticals Inc. (DOVA) | 01-Jul-19 | Private Sale (Planned) | 1,308 | $14.17 | $18,534.40 | (2%) 68.3K to 66.99K | |
| 02-Jul-19 4:56 PM View: | Allen Lee F Md Phd Chief Medical Officer | Dova Pharmaceuticals Inc. (DOVA) | 01-Jul-19 | Private Sale (Planned) | 1,957 | $14.19 | $27,769.80 | (16%) 12.57K to 10.61K | |
| 02-Jul-19 4:55 PM View: | Hoitt Jason Chief Commercial Officer | Dova Pharmaceuticals Inc. (DOVA) | 28-Jun-19 | Private Sale (Planned) | 2,387 | $13.81 | $32,963.50 | (11%) 22.32K to 19.94K | |
| 01-Jul-19 7:23 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 28-Jun-19 | Purchase | 100,000 | $14.17 | $1,417,090.00 | 3% 3.45M to 3.55M | |
| 01-Jul-19 7:23 PM View: | Perceptive Advisors LLC 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 27-Jun-19 | Purchase | 327,209 | $13.10 | $4,286,120.00 | 10% 3.13M to 3.45M | |
| 27-Jun-19 4:21 PM View: | Goldman Steven M. Director | Dova Pharmaceuticals Inc. (DOVA) | 26-Jun-19 | Option Exercise | 1,750 | $8.29 | $14,511.40 | 1% 147.53K to 149.28K | 13% |
| 24-Jun-19 4:54 PM View: | Goldman Steven M. Director | Dova Pharmaceuticals Inc. (DOVA) | 20-Jun-19 | Option Exercise | 1,750 | $8.29 | $14,509.30 | 1% 145.78K to 147.53K | 13% |
| 03-Jun-19 8:35 PM View: | Goldman Steven M. Director | Dova Pharmaceuticals Inc. (DOVA) | 13-May-19 | Option Exercise | 3,668 | $7.32 | $26,849.80 | 3% 142.11K to 145.78K | |
| 10-Apr-19 4:48 PM View: | Hoitt Jason Chief Commercial Officer | Dova Pharmaceuticals Inc. (DOVA) | 08-Apr-19 | Market Sale (Planned) | 2,387 | $8.77 | $20,934.00 | (10%) 24.71K to 22.32K | 3% |
| 08-Mar-19 8:46 AM View: | Manning Paul B Director 10% Owner | Dova Pharmaceuticals Inc. (DOVA) | 07-Mar-19 | Market Purchase | 68,000 | $7.48 | $508,640.00 | < 1% 14.67M to 14.73M | (< 1%) |
| 07-Feb-19 4:57 PM View: | Novak Alfred J Director | Dova Pharmaceuticals Inc. (DOVA) | 05-Feb-19 | Grant | 6,901 | -- | -- | 100% 0 to 6.9K | |
| 07-Feb-19 4:59 PM View: | Jeffs Roger Director | Dova Pharmaceuticals Inc. (DOVA) | 05-Feb-19 | Grant | 6,901 | -- | -- | 11% 61.4K to 68.3K | |
| 07-Feb-19 5:00 PM View: | Goldman Steven M. Director | Dova Pharmaceuticals Inc. (DOVA) | 05-Feb-19 | Grant | 7,528 | -- | -- | 6% 130.0K to 137.53K | |
| 07-Feb-19 4:55 PM View: | Wysenski Nancy Director | Dova Pharmaceuticals Inc. (DOVA) | 05-Feb-19 | Grant | 6,274 | -- | -- | 100% 0 to 6.27K | |
| 08-Jan-19 5:01 PM View: | Laliberte Kevin Sr. VP, Product Development | Dova Pharmaceuticals Inc. (DOVA) | 04-Jan-19 | Grant | 7,937 | -- | -- | 128% 6.2K to 14.14K | |
| 08-Jan-19 4:59 PM View: | Hahn Mark W Chief Financial Officer | Dova Pharmaceuticals Inc. (DOVA) | 04-Jan-19 | Grant | 8,844 | -- | -- | 354% 2.5K to 11.34K | |
| 08-Jan-19 4:57 PM View: | Allen Lee F Md Phd Chief Medical Officer | Dova Pharmaceuticals Inc. (DOVA) | 04-Jan-19 | Grant | 9,070 | -- | -- | 259% 3.5K to 12.57K |
